Category:Liande LI of Dallas TX (US)
Contents
Liande LI of Dallas TX (US)
Executive Summary
Liande LI of Dallas TX (US) is an inventor who has filed 2 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (2 patents), Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca (2 patents), Drugs for disorders of the nervous system (2 patents), and they have worked with companies such as The Board of Regents of The University of Texas System (2 patents). Their most frequent collaborators include (2 collaborations).
Patent Filing Activity
Technology Areas
List of Technology Areas
- C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 2 patents
- A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 2 patents
- A61P25/00 (Drugs for disorders of the nervous system): 2 patents
- C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- C12N2310/315 (of the backbone): 2 patents
- C12N2310/3231 (modified ring structure): 2 patents
Companies
List of Companies
- The Board of Regents of The University of Texas System: 2 patents
Collaborators
- David COREY of Dallas TX (US) (2 collaborations)
Subcategories
This category has the following 2 subcategories, out of 2 total.